RedHill Biopharma Ltd. (RDHL) to Present at the 25th Annual ROTH Conference  
3/6/2013 11:07:31 AM

TEL-AVIV, Israel, March 6, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, patent-protected, new formulations and combinations of existing drugs, today announced that Dror Ben-Asher, the Company's Chief Executive Officer, will present an overview of the Company at the 25th Annual ROTH Conference. The RedHill presentation will take place at the Ritz Carlton in Laguna Niguel, on Tuesday, March 19, 2013 at 10:30am PDT.